Hemostemix Inc. HEM.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -3.33M | -3.04M | -3.36M | -2.41M | -2.22M |
| Total Depreciation and Amortization | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -310.30K | -197.10K | 363.20K | 742.20K | 1.09M |
| Change in Net Operating Assets | -170.80K | -879.40K | -291.60K | -2.07M | -536.20K |
| Cash from Operations | -3.81M | -4.12M | -3.29M | -3.75M | -1.67M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -200.00 | -200.00 | -101.60K | -101.40K | -101.40K |
| Cash from Investing | -200.00 | -200.00 | -101.60K | -101.40K | -101.40K |
| Total Debt Issued | 749.80K | 749.80K | 749.80K | -- | -- |
| Total Debt Repaid | -1.25M | -1.25M | -1.25M | -- | -- |
| Issuance of Common Stock | 5.23M | 5.39M | 5.16M | 6.42M | 3.04M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 3.43M | 3.55M | 3.37M | 4.63M | 2.17M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -389.20K | -572.60K | -19.60K | 779.70K | 403.30K |